The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus-Reference-Cited by-同舟云学术

The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus

Published:2021-10-31 Issue:2 Volume:9 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Hort Michael¹,Bertsche Ute²,Nozinovic Senada³,Dietrich Alina¹,Schrötter Anne Sophie¹,Mildenberger Laura¹,Axtmann Katharina¹,Berscheid Anne¹^ORCID,Bierbaum Gabriele¹^ORCID

Affiliation:

1. Institute of Medical Microbiology, Immunology and Parasitology, University Clinics of Bonn, Bonn, Germany

2. Department of Infection Biology, University of Tuebingen, Tuebingen, Germany

3. Department of Chemistry, University of Bonn, Bonn, Germany

Abstract

Infections with methicillin-resistant Staphylococcus aureus are commonly treated with vancomycin. This antibiotic inhibits cell wall biosynthesis by binding to the cell wall building block lipid II.

Funder

Deutsche Forschungsgemeinschaft

Fonds National de la Recherche Luxembourg

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/Spectrum.00528-21

Reference66 articles.

1. Staphylococcus aureus from the German general population is highly diverse

2. Vancomycin: A History